Retinoid-related orphan receptor gamma t is a potential therapeutic target for controlling inflammatory autoimmunity (Q28302355)

Expert Opinion on Therapeutic Targets

Europe PubMed Central

title

Retinoid-related orphan receptor gamma t is a potential therapeutic target for controlling inflammatory autoimmunity (English)

0 references

0 references

Zhaofeng Huang

1

0 references

Huimin Xie

series ordinal

2

0 references

Ruiqing Wang

series ordinal

3

0 references

Zuoming Sun

series ordinal

4

0 references

language of work or name

English

0 references

publication date

June 2007

0 references

published in

0 references

volume

11

0 references

page(s)

737-43

0 references

issue

6

0 references

cites work

Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.6.737

An essential function for the nuclear receptor RORgamma(t) in the generation of fetal lymphoid tissue inducer cells

21 April 2017

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.6.737

Thymic origin of intestinal alphabeta T cells revealed by fate mapping of RORgammat+ cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.6.737

Requirement for RORgamma in thymocyte survival and lymphoid organ development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.6.737

Selective LXXLL peptides antagonize transcriptional activation by the retinoid-related orphan receptor RORgamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.6.737

A signature motif in transcriptional co-activators mediates binding to nuclear receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.6.737

The steroid receptor coactivator-1 contains multiple receptor interacting and activation domains that cooperatively enhance the activation function 1 (AF1) and AF2 domains of steroid receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.6.737

Nuclear receptor coactivators: multiple enzymes, multiple complexes, multiple functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.6.737

The coactivator TIF2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.6.737

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.6.737

The role of the nuclear hormone receptor RORγt in the development of lymph nodes and Peyer's patches

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.6.737

Expanding the effector CD4 T-cell repertoire: the Th17 lineage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.6.737

A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.6.737

IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.6.737

IL-17E, a novel proinflammatory ligand for the IL-17 receptor homolog IL-17Rh1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.6.737

Cloning and characterization of IL-17B and IL-17C, two new members of the IL-17 cytokine family

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.6.737

IL-23 drives a pathogenic T cell population that induces autoimmune inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.6.737

IL-12- and IL-23-induced T helper cell subsets: birds of the same feather flock together

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.6.737

Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.6.737

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.6.737

Transforming growth factor-beta induces development of the T(H)17 lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.6.737

TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.6.737

Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.6.737

Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.6.737

Transforming growth factor-beta in T-cell biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.6.737

Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.6.737

Th17: an effector CD4 T cell lineage with regulatory T cell ties

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.6.737

The role of T-cell interleukin-17 in conducting destructive arthritis: lessons from animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.6.737

Interleukin-17 and airway remodelling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.6.737

Increased expression of interleukin 17 in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.6.737

Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.6.737

The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.6.737

Free, soluble interleukin-17 protein during severe inflammation in human airways

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.6.737

IL-17-induced cytokine release in human bronchial epithelial cells in vitro: role of mitogen-activated protein (MAP) kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.6.737

Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.6.737

The role of IL-12, IL-23 and IFN-gamma in immunity to viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.6.737

The role of interleukin-12 in human infectious diseases: only a faint signature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.6.737

Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.6.737

RORgamma t, a novel isoform of an orphan receptor, negatively regulates Fas ligand expression and IL-2 production in T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.6.737

Interleukin-17 family members and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.6.737

Network communications: lymphotoxins, LIGHT, and TNF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.6.737

Interleukin 6: from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.6.737

The IL-23/Th(17) axis: therapeutic targets for autoimmune inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.6.737

Rationale and safety of anti-interleukin-23 and anti-interleukin-17A therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.6.737

Genetic evidence supporting selection of the Valpha14i NKT cell lineage from double-positive thymocyte precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.6.737

Recent advances in the mechanisms of action and physiological functions of the retinoid-related orphan receptors (RORs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.6.737